Sponsor Pipeline

Clarion Cells, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT04631406
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic…		 Sponsor changed: Stanford University -> Clarion Cells, Inc.
2026-08-12 NCT04631406
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic…		 Enrollment reduced: 30 -> 27 participants
2026-08-12 NCT04631406
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic…		 Sponsor changed: Gary Steinberg, MD, PhD -> Stanford University
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07709845 CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic… Chronic Ischemic Stroke Not Yet Recruiting
Phase 1/2
NCT04631406 A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic… Ischemic Stroke Active, Not Recruiting
Disease Areas
Stroke (2)
Get alerts when Clarion Cells, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free